Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Bullboard Posts
Post by zeon123on Apr 06, 2016 10:59pm
168 Views
Post# 24739335

Starting to look at some numbers

Starting to look at some numbers

canopy =   8200 patients reported 31 decembre |256m cap | 37.5% diff- from today close 2.53$  whit the All time high close

 

mettrum = 6100 patients reported in february  |50m cap  | 64% diff- from today close 2.53$  whit the All time high close

 

Aphria =4000 patients reported in february | 83 m cap | 18% diff- from today close 2.53$  whit the All time high close

Those numbers make me wonder, should I temporary put my money on Mettrum wich is less pricey than the others. Still have a good amount of patients and oil licence. My guess is the industry will drift lower until news of Bill Blair team ready to work with province. I think CGC is a great company, but their money consumption make me worry. Until legalisation path become clearer maybe could it be wiser to invest in a LP who offers good returns for my investment. I know that CGC is the bigger right now. I suppose the return could be more potential with Mettrum who is 64% away from highest close compared with CGC 37.5%. What's your guess ?? 

Bullboard Posts